|
Immunotherapy
Citations 151-160 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells
- Lucie Heinzerling, Valerie Künzi, Patrick A. Oberholzer, Thomas Kündig, Hussein Naim, and Reinhard Dummer
Blood 2005; 106: 2287-2294.
[Abstract]
[Full text]
[PDF]
Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking
- Xin Chen, Takaya Murakami, Joost J. Oppenheim, and O. M. Zack Howard
Blood 2005; 106: 2409-2416.
[Abstract]
[Full text]
[PDF]
Systemic administration of a TLR7 ligand leads to transient immune incompetence due to peripheral-blood leukocyte depletion
- Matthias Gunzer, Helge Riemann, Yasmin Basoglu, Anja Hillmer, Carsten Weishaupt, Sandra Balkow, Bernd Benninghoff, Beat Ernst, Meike Steinert, Thomas Scholzen, Cord Sunderkötter, and Stephan Grabbe
Blood 2005; 106: 2424-2432.
[Abstract]
[Full text]
[PDF]
Diphtheria toxin fused to variant human interleukin-3 induces cytotoxicity of blasts from patients with acute myeloid leukemia according to the level of interleukin-3 receptor expression
- Ugo Testa, Roberta Riccioni, Mauro Biffoni, Daniela Diverio, Francesco Lo-Coco, Robin Foà, Cesare Peschle, and Arthur E. Frankel
Blood 2005; 106: 2527-2529.
[Abstract]
[Full text]
[PDF]
Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria
- Anita Hill, Peter Hillmen, Stephen J. Richards, Dupe Elebute, Judith C. Marsh, Jason Chan, Christopher F. Mojcik, and Russell P. Rother
Blood 2005; 106: 2559-2565.
[Abstract]
[Full text]
[PDF]
Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases
- Fadi Fakhouri, Jean-Paul Vernant, Agnès Veyradier, Martine Wolf, Gilles Kaplanski, Raynald Binaut, Manfred Rieger, Friedrich Scheiflinger, Pascale Poullin, Benjamin Deroure, Richard Delarue, Philippe Lesavre, Philippe Vanhille, Olivier Hermine, Giuseppe Remuzzi, and Jean-Pierre Grünfeld
Blood 2005; 106: 1932-1937.
[Abstract]
[Full text]
[PDF]
T cell–mediated suppression of angiogenesis results in tumor protective immunity
- He Zhou, Yunping Luo, Masato Mizutani, Noriko Mizutani, Ralph A. Reisfeld, and Rong Xiang
Blood 2005; 106: 2026-2032.
[Abstract]
[Full text]
[PDF]
Defective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patients
- Cyril Fauriat, Alessandro Moretta, Daniel Olive, and Régis T. Costello
Blood 2005; 106: 2186-2188.
[Abstract]
[Full text]
[PDF]
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010
- Lawrence D. Kaplan, Jeannette Y. Lee, Richard F. Ambinder, Joseph A. Sparano, Ethel Cesarman, Amy Chadburn, Alexandra M. Levine, and David T. Scadden
Blood 2005; 106: 1538-1543.
[Abstract]
[Full text]
[PDF]
Chimeric NK-receptor–bearing T cells mediate antitumor immunotherapy
- Tong Zhang, Bethany A. Lemoi, and Charles L. Sentman
Blood 2005; 106: 1544-1551.
[Abstract]
[Full text]
[PDF]
|
|
